Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Dimethyl fumarate in Tecfidera qualifies as new active substance in Europe

Nov. 25, 2013

Topina approved for pediatric use in Japan

Nov. 25, 2013

Terumo launches intravenous acetaminophen in Japan

Nov. 25, 2013

Aphios spins off Amylon to develop Alzheimer's disease drug

Nov. 25, 2013

Paxil tablets approved for post-traumatic stress disorder in Japan

Nov. 22, 2013

DM-1992 shows promising plasma concentration-time profiles in phase II trials

Nov. 22, 2013

Researchers at Pfizer synthesize novel BACE1/2 inhibitors for Alzheimer's disease

Nov. 22, 2013

Abilify Maintena approved in E.U. for maintenance treatment of schizophrenia

Nov. 22, 2013

Kyowa Hakko Kirin begins international phase III study of istradefylline

Nov. 22, 2013

FDA issues complete response letter for cariprazine

Nov. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...